The project is based on the revolutionary CRISPR/cas9 genome editing technology.
The universities received a US-Russia University Partnership Program grant.
The participants are the Institute of Fundamental Medicine and Biology at KFU and the Department of Biology together with the Center for Computational and Integrative Biology at Rutgers.
The application was a part of the new 7P Translational Medicine strategy of KFU. This strategy includes working on partnerships with leading overseas researchers, including members of the Russian-American Science Association.
KFU's side will mostly be represented by the Tumor Pathogenesis Lab headed by Ilya Serebriiskii (Fox Chase Cancer Center). The Lab is a part of the KFU-RASA Center for Translational Medicine.
The curators are Chair of the Department of Biochemistry and Biotechnology, Professor Ramziya Kiyamova (KFU) and Professor Andrey Grigoriev (Rutgers).